Meanwhile, FOXP3 inhibition reduced circRUNX1-induced ESCC cell mobility, as demonstrated by transwell and wound healing experiments (Fig. 3K-M and Fig. S5D-F). This evidence concerns the gene FOXP3 and esophageal squamous cell carcinoma.